bih.button.backtotop.text

Narongsak Kiatikajornthada, M.D.

Specialties

Hematology & Oncology

Language spoken

Thai, English

Qualifications

Medical School

- M.D., Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, 1969

Board Certifications

- Diplomate of the American Board of Internal Medicine, 1974
- Diplomate of the American Board of Hematology, 1976
- Diploma of the Thai Board of Medical Oncology, 1997

Fellowships

- Hematology, The Bronx-Lebanon Hospital, New York, USA, 1973-1975

Special Clinical Trainings

- HMX Pro Genetics-Cancer Genomics and Precision Oncology, Harvard Medical School, USA, 2022
- Certificate of Cancer Genomics and Precision Oncology, 2023 - 2028

Special Clinical Interests

- Oncology Lung and Gastrointestinal


Medical Experience

Founding & Leadership:| • One of the founders of the Thai Society of Clinical Oncology (1996)| • Founder and co-organizer of major clinical oncology initiatives in Thailand| • Elected Chairman of Department of Medical Oncology, Bumrungrad Hospital (2021–Present)| • Co-Director, Horizon Regional Cancer Center at Bumrungrad Hospital (2001–2022)| • Elected Chairman, Department of Medicine, Bumrungrad Hospital (2003–2006)| Clinical Research & Publications:| • Published 5 peer-reviewed articles in high-impact international journals including:| o Journal of Clinical Oncology (37(15), suppl, 6553)| o Annals of Oncology (30, v583)| o Journal of Global Oncology (5, suppl, 95)| o Journal of the American Medical Informatics Association (28(4), 832–838)| • Principal investigator in multiple Phase III multinational clinical trials| • Expertise in cancer genomics and precision oncology|


Research & Publications

Peer-Reviewed Journal Articles
1. Suwanvecho, S., Shortliffe, E. H., Suwanrusme, H., Issarachai, S., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Keyaert, S., Dankwa-Mullan, I., Esquivel, J., Patel, V. L., Jackson, G., & Kiatkijarornthada, N. (2019). A blinded evaluation of a clinical decision-support system at a regional cancer care center. Journal of Clinical Oncology, 37(15_suppl), 6553. https://doi.org/10.1200/jco.2019.37.15_suppl.6553
2. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A. M., Solomon, M., Wang, S., Hekmat, R., Esquivel, J., Dankwa-Mullan, I., Patel, V. L., Shortliffe, E., Arriaga, Y. E., Jackson, G. P., & Kiatkijarornthada, N. (2020). Associations between concordance with oncology clinical decision support and clinical outcomes in lung cancer patients. Journal of Clinical Oncology, 38(15_suppl), e14114. https://doi.org/10.1200/jco.2020.38.15_suppl.e14114
3. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Issarachai, S., Taechakraichana, N., Lungchukiet, P., Decha, W., Boonpakdee, W., Thanakarn, N., Wongattananon, P., Preininger, A. M., Solomon, M., Wang, S., Hekmat, R., Dankwa-Mullan, I., Shortliffe, E., Patel, V. L., Arriaga, Y., Jackson, G. P., & Kiatkijarornthada, N. (2021). Comparison of an oncology clinical decision-support system’s recommendations with actual treatment decisions. Journal of the American Medical Informatics Association, 28(4), 832–838. https://doi.org/10.1093/jamia/ocaa334
4. Suwanvecho, S., Suwanrusme, H., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Dankwa-Mullan, I., Solomon, M., Wang, S., Jackson, G., Patel, V., Shortliffe, E., & Kiatkijarornthada, N. (2019). A blinded comparison of patient treatments to therapeutic options presented by an artificial intelligence-based clinical decision-support system. Annals of Oncology, 30, v583. https://doi.org/10.1093/annonc/mdz257.030
5. Suwanvecho, S., Suwanrusme, H., Issarachai, S., Jirakulaporn, T., Taechakraichana, N., Lungchukiet, P., Thanakarn, N., Decha, W., Boonpakdee, W., Wongattananon, P., Preininger, A., Arriaga, Y. E., Solomon, M., Wang, S., Dankwa-Mullan, I., Esquivel, J., Jackson, G., Patel, V. L., Shortliffe, E., & Kiatkijarornthada, N. (2019). Concordance between a clinical decision-support system and treatments selected by clinicians as a function of cancer type or stage. Journal of Global Oncology, 5(suppl), 95. https://doi.org/10.1200/jgo.2019.5.suppl.95

Clinical Trial Leadership
• Randomized Phase III multinational trial: Bevacizumab with Capecitabine and Oxaliplatin for colorectal cancer
• Expanded access program coordination for Tarceva (Erlotinib) in advanced non-small cell lung cancer
• Multi-center Phase III study assessing Gefitinib versus Carboplatin/Paclitaxel as first-line treatment for advanced non-small cell lung cancer in Asia


Doctor's Schedule

Day Time Location
Mon1 08:00 - 12:0008:0012:00 Horizon Cancer Center (Building B 3rd Floor)
Tue2 08:00 - 12:0008:0012:00 Horizon Cancer Center (Building B 3rd Floor)
Wed3 08:00 - 12:0008:0012:00 Horizon Cancer Center (Building B 3rd Floor)